Company profile · Düsseldorf, Germany

Gerresheimer

Primary Packaging, Drug Delivery Systems, and Pharma Industrial Supply · Global pharma industrial supply

Gerresheimer enters the German core with an officially documented November 2025 interim-CEO transition and a live pharma-packaging systems role.

Lead
Uwe Röhrhoff (verified ↗)
Address
Peter-Müller-Straße 3, 40468 Düsseldorf, Germany (source ↗)
Compliance
GMP · ISO-13485
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Global pharma industrial supply
Capabilities
Drug Containment Solutions · Drug Delivery Systems · Industrial Supply for Pharma and Biotech
Founded
1864
Headcount
10000+
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Uwe Röhrhoff

Interim Chief Executive Officer

Check official leadership source
Full addressPeter-Müller-Straße 3, 40468 Düsseldorf, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Gerresheimer Düsseldorf headquarters page naming Peter-Müller-Straße 3, Düsseldorf.

Open source
Operating profile

Global pharma industrial supply

Düsseldorf, Germany. Primary Packaging, Drug Delivery Systems, and Pharma Industrial Supply. Review completed on 14 Mar 2026.

2026 technical specializationPrimary Packaging, Drug Delivery Systems, and Pharma Industrial Supply
Core capabilities
Drug Containment SolutionsDrug Delivery SystemsIndustrial Supply for Pharma and Biotech
Governance

German, EU, and global packaging-device oversight

Regulated pharmaceutical packaging systems, Medical-device and pharma industrial quality systems

Editorial note

Primary Packaging, Drug Delivery Systems, and Pharma Industrial Supply

Gerresheimer enters the German core with an officially documented November 2025 interim-CEO transition and a live pharma-packaging systems role.

Editorial note

Gerresheimer enters the German core with an officially documented November 2025 interim-CEO transition and a live pharma-packaging systems role.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Drug Containment Solutions
Drug Delivery Systems
Industrial Supply for Pharma and Biotech
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceGerresheimer official management detail page confirming Uwe Röhrhoff as CEO from November 2025.Source origin: gerresheimer.comOpen source
Supporting evidenceGerresheimer official October 2025 corporate news on the interim CEO transition.Source origin: gerresheimer.comOpen source
Physical-site evidenceOfficial Gerresheimer Düsseldorf headquarters page naming Peter-Müller-Straße 3, Düsseldorf.Source origin: gerresheimer.comOpen source
Infrastructure

Declared infrastructure

Packaging systems production
Device-manufacturing lines
Quality-control laboratories
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
VERIFIED ACTIVE 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Gerresheimer located?
Gerresheimer operates from Peter-Müller-Straße 3, 40468 Düsseldorf, Germany, Düsseldorf, Germany.
Who runs Gerresheimer?
Gerresheimer is led by Uwe Röhrhoff, Interim Chief Executive Officer. Verified 14 Mar 2026.
What does Gerresheimer do?
Gerresheimer enters the German core with an officially documented November 2025 interim-CEO transition and a live pharma-packaging systems role. Core capabilities: Drug Containment Solutions, Drug Delivery Systems, Industrial Supply for Pharma and Biotech.
Editorial context

Related technical briefs

Briefs that name Düsseldorf as a covered market or city.